Skip to content

OS Therapies OSTX Total Current Assets

Total Current Assets at other companies

Immunome logo
ImmunomeIMNM
$594.31M+83.9%
CTO
Citius Oncology, Inc.CTOR
$29.42M+63.1%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$88.83M-30.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$844M-18.1%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$452.95M+315%
WHW
Whitehawk Therapeutics, Inc. Common StockWHWK
$125.55M-46.0%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+66.4%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's total current assets?
OS Therapies (OSTX) reported total current assets of $917.55K in Q1 2026.
How has OS Therapies's total current assets changed year-over-year?
OS Therapies's total current assets decreased by 77.6% year-over-year, from $4.1M to $917.55K.
What is the long-term trend for OS Therapies's total current assets?
Over 2 years (2023 to 2025), OS Therapies's total current assets has grown at a -35.1% compound annual growth rate (CAGR), from $790.03K to $332.91K.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.